Last reviewed · How we verify
NCT07089004: Hypogamnesamia
Hypomagnesemia and Its Clinical Outcome
trial testing No intervention (observational study) in Hypomagnesemia in 112 participants. Completed in 25 April 2025.
31 December 2024
Quick facts
| Lead sponsor | Bangladesh Bioscience Research Group |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 1 June 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 25 April 2025 |
| Sites | 1 location across Bangladesh |
Drugs / interventions tested
- No intervention (observational study) — full drug profile →
Conditions studied
- Hypomagnesemia — all drugs for Hypomagnesemia →
- Critical Illness — all drugs for Critical Illness →
- Intensive Care Unit (ICU) Patients — all drugs for Intensive Care Unit (ICU) Patients →
- Scoring Systems — all drugs for Scoring Systems →
Sponsor
Bangladesh Bioscience Research Group
Who can join
Adults 18 to 80, any sex, with Hypomagnesemia or Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Magnesium is an essential electrolyte involved in numerous physiological processes, including maintaining cellular integrity, regulating muscle tone, supporting cardiovascular function, and modulating immune responses. Despite its critical role, magnesium is often overlooked in clinical practice, earning it the title of the "forgotten electrolyte." Hypomagnesemia, defined as serum magnesium levels below 1.5 mEq/L, has been associated with adverse clinical outcomes such as increased mortality, prolonged ICU stays, and higher requirements for mechanical ventilation. Critically ill patients are particularly vulnerable to hypomagnesemia due to various underlying conditions, gastrointestinal losses, and renal complications. However, limited data are available from Bangladesh on the burden and clinical impact of hypomagnesemia in ICU settings. This study aims to assess the correlation between hypomagnesemia and clinical outcomes, including length of ICU stay, need for mechanical ventilation, and mortality among critically ill patients in a tertiary care ICU in Bangladesh.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07089004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention (observational study)
Trials testing the same drug.
- NCT07527676 — Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes · not yet recruiting
- NCT07527000 — SpO2 Validation Study - All.Health Algo Oximeter Software · not yet recruiting
- NCT07495735 — Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellula · not yet recruiting
- NCT07504406 — Assessment of Medication Adherence in Ccu Admitted Patients · not yet recruiting
- NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
Other recruiting trials for Hypomagnesemia
Currently open trials in the same condition.
- NCT05998863 — EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy · Phase 3 · recruiting
Other Bangladesh Bioscience Research Group trials
Trials by the same sponsor.
- NCT07207551 — Prevalence of Hemoglobinopathies Associated With Significant Hb Variants in the Chattogram Region of Bangladesh · completed
- NCT07305181 — Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07089004 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bangladesh Bioscience Research Group
- Last refreshed: 28 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07089004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing